СЛУЧАЙ ВТОРИЧНОЙ ТРОМБОТИЧЕСКОЙ ТРОМБОЦИТОПЕНИЧЕСКОЙ ПУРПУРЫ, ВЫЗВАННОЙ COVID-19
Аннотация
В статье приводится анализ клинического случая развития тромботической тромбоцитопенической пурпуры (ТТП) у пациента с верифицированной инфекцией COVID-19. Представлен алгоритм постановки диагноза ТТП в условиях недоступности тестирования биомаркера ADAMTS13. Приведена схема эффективного лечения ТТП с использованием плазмообмена, метилпреднизолона и ритуксимаба.
Литература
Joly BS, Coppo P, Veyradier A. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2019;12(6):383-395. https://doi.org/10.1080/17474086.2019.1611423.
Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836-2846. https://doi.org/10.1182/blood-2016-10-709857.
Douglas KW, Pollock KG, Young D, Catlow J, Green R. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apher. 2010;25(2):47-53. https://doi.org/10.1002/jca.20226.
Wang Z, Yu Z, Su J, Cao L, Zhao X, Ruan C. Sepsisinduced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome. Clin Appl Thromb Hemost. 2011;17(3):251-253. https://doi.org/10.1177/1076029609357739.
Smeets NJL, Fijnheer R, Sebastian S, De Mast Q. Secondary thrombotic microangiopathy with severely reduced ADAMTS13 activity in a patient with Capnocytophaga canimorsus sepsis: a case report. Transfusion. 2018;58(10):2426-2429. https://doi.org/10.1111/trf.14829.
Dorooshi G, Lalehzar SS, Nasri M, Meamar R. Thrombotic Thrombocytopenic Purpura with Conjunctivitis in a Patient with Coronavirus Disease 2019 Infection. Adv Biomed Res. 2020;9:71. https://doi.org/10.4103/abr.abr_190_20.
Scully M. Hereditary thrombotic thrombocytopenic purpura. Haematologica. 2019;104(10):1916-1918. https://doi.org/10.3324/haematol.2019.225896.
Hosler GA, Cusumano AM, Hutchins GM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med. 2003;127(7):834-9. https://doi.org/10.5858/2003-127-834-TTPAHU.
Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One. 2010;5(4):e10208. https://doi.org/10.1371/journal.pone.0010208.
Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, OjedaUribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y. Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre. Am J Hematol. 2017;92(4):381-387. https://doi.org/10.1002/ajh.24665.
Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007;12(1):11-19. https://doi.org/10.1634/theoncologist.12-1-11.
Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011;86(9):743-51. https://doi.org/10.1002/ajh.22091.
Nguyen TC, Han YY. Plasma exchange therapy for thrombotic microangiopathies. Organogenesis. 2011;7(1):28-31. https://doi.org/10.4161/org.7.1.14027.
Thejeel B, Garg AX, Clark WF, Liu AR, Iansavichus AV, Hildebrand AM. Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review. Am J Hematol. 2016;91(6):623-630. https://doi.org/10.1002/ajh.24339.
Westwood JP, Thomas M, Alwan F, McDonald V, Benjamin S, Lester WA, Lowe GC, Dutt T, Hill QA, Scully M. Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens. Blood Adv. 2017;1(15):1159-1166. https://doi.org/10.1182/bloodadvances.2017008268.
